Research location
Quezon City
NCR, Philippines
Advertisement
Research activity in Quezon City
NCR, PhilippinesCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Quezon City
8 linked trials · page 1 of 1A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung CancerNCT06311721 · 2024-09-09 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)NCT01989676 · 2014-02-24 · 1 site observation
COMPLETED
Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderNCT01255787 · 2010-11-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)NCT01111552 · 2010-07-29 · 2 site observations
TERMINATED
Colloids in Severe TraumaNCT00890383 · 2009-05-01 · 1 site observation
COMPLETED
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaNCT00731549 · 2008-12-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes MellitusNCT00690638 · 2008-07-01 · 1 site observation
COMPLETED
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaNCT00705783 · 2008-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.